185 related articles for article (PubMed ID: 25431858)
21. Discovery and biological activity of new chondramides from Chondromyces sp.
Herrmann J; Hüttel S; Müller R
Chembiochem; 2013 Sep; 14(13):1573-80. PubMed ID: 23959765
[TBL] [Abstract][Full Text] [Related]
22. Total synthesis and biological activity of dolastatin 16.
Casalme LO; Yamauchi A; Sato A; Petitbois JG; Nogata Y; Yoshimura E; Okino T; Umezawa T; Matsuda F
Org Biomol Chem; 2017 Feb; 15(5):1140-1150. PubMed ID: 28074955
[TBL] [Abstract][Full Text] [Related]
23. Hybrids of the hemiasterlin analogue taltobulin and the dolastatins are potent antimicrotubule agents.
Zask A; Kaplan J; Musto S; Loganzo F
J Am Chem Soc; 2005 Dec; 127(50):17667-71. PubMed ID: 16351096
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, solution structure, and bioactivity of six new simplified analogues of the natural cyclodepsipeptide jaspamide.
Terracciano S; Bruno I; Bifulco G; Avallone E; Smith CD; Gomez-Paloma L; Riccio R
Bioorg Med Chem; 2005 Sep; 13(17):5225-39. PubMed ID: 16023351
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and cytotoxicity of a new class of potent decapeptide macrocycles.
Davis MR; Styers TJ; Rodriguez RA; Pan PS; Vasko RC; McAlpine SR
Org Lett; 2008 Jan; 10(2):177-80. PubMed ID: 18095697
[TBL] [Abstract][Full Text] [Related]
26. Antineoplastic agents 365. Dolastatin 10 SAR probes.
Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Boyd MR; Hamel E; Pettit RK; Hogan F; Bai R; Chapuis JC; McAllister SC; Schmidt JM
Anticancer Drug Des; 1998 Jun; 13(4):243-77. PubMed ID: 9627667
[TBL] [Abstract][Full Text] [Related]
27. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, conformational analysis, and cytotoxicity of conformationally constrained aplidine and tamandarin A analogues incorporating a spirolactam beta-turn mimetic.
Gutiérrez-Rodríguez M; Martín-Martínez M; García-López MT; Herranz R; Cuevas F; Polanco C; Rodríguez-Campos I; Manzanares I; Cárdenas F; Feliz M; Lloyd-Williams P; Giralt E
J Med Chem; 2004 Nov; 47(23):5700-12. PubMed ID: 15509169
[TBL] [Abstract][Full Text] [Related]
29. Targeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.
Gianolio DA; Rouleau C; Bauta WE; Lovett D; Cantrell WR; Recio A; Wolstenholme-Hogg P; Busch M; Pan P; Stefano JE; Kramer HM; Goebel J; Krumbholz RD; Roth S; Schmid SM; Teicher BA
Cancer Chemother Pharmacol; 2012 Sep; 70(3):439-49. PubMed ID: 22821053
[TBL] [Abstract][Full Text] [Related]
30. Effects of the antimitotic natural product dolastatin 10, and related peptides, on the human malarial parasite Plasmodium falciparum.
Fennell BJ; Carolan S; Pettit GR; Bell A
J Antimicrob Chemother; 2003 Apr; 51(4):833-41. PubMed ID: 12654761
[TBL] [Abstract][Full Text] [Related]
31. Efficient solid-phase synthesis of FK228 analogues as potent antitumoral agents.
Di Maro S; Pong RC; Hsieh JT; Ahn JM
J Med Chem; 2008 Nov; 51(21):6639-41. PubMed ID: 18839938
[TBL] [Abstract][Full Text] [Related]
32. Auristatin PYE, a novel synthetic derivative of dolastatin 10, is highly effective in human colon tumour models.
Shnyder SD; Cooper PA; Millington NJ; Pettit GR; Bibby MC
Int J Oncol; 2007 Aug; 31(2):353-60. PubMed ID: 17611692
[TBL] [Abstract][Full Text] [Related]
33. Novel C2-C3' N-peptide linked macrocyclic taxoids. Part 2: synthesis and biological activities of docetaxel analogues with a peptide side chain at C2 and their macrocyclic derivatives.
Larroque AL; Dubois J; Thoret S; Aubert G; Chiaroni A; Guéritte F; Guénard D
Bioorg Med Chem; 2007 Jan; 15(1):563-74. PubMed ID: 17064914
[TBL] [Abstract][Full Text] [Related]
34. An array of bengamide E analogues modified at the terminal olefinic position: synthesis and antitumor properties.
Martín-Gálvez F; García-Ruiz C; Sánchez-Ruiz A; Valeriote FA; Sarabia F
ChemMedChem; 2013 May; 8(5):819-31. PubMed ID: 23512621
[TBL] [Abstract][Full Text] [Related]
35. Discovery and optimization of pyrimidone indoline amide PI3Kβ inhibitors for the treatment of phosphatase and tensin homologue (PTEN)-deficient cancers.
Certal V; Carry JC; Halley F; Virone-Oddos A; Thompson F; Filoche-Rommé B; El-Ahmad Y; Karlsson A; Charrier V; Delorme C; Rak A; Abecassis PY; Amara C; Vincent L; Bonnevaux H; Nicolas JP; Mathieu M; Bertrand T; Marquette JP; Michot N; Benard T; Perrin MA; Lemaitre O; Guerif S; Perron S; Monget S; Gruss-Leleu F; Doerflinger G; Guizani H; Brollo M; Delbarre L; Bertin L; Richepin P; Loyau V; Garcia-Echeverria C; Lengauer C; Schio L
J Med Chem; 2014 Feb; 57(3):903-20. PubMed ID: 24387221
[TBL] [Abstract][Full Text] [Related]
36. Discovery of azaisoerianin derivatives as potential antitumors agents.
Soussi MA; Provot O; Bernadat G; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Brion JD; Messaoudi S; Alami M
Eur J Med Chem; 2014 May; 78():178-89. PubMed ID: 24681982
[TBL] [Abstract][Full Text] [Related]
37. Total synthesis and biological evaluation of largazole and derivatives with promising selectivity for cancers cells.
Zeng X; Yin B; Hu Z; Liao C; Liu J; Li S; Li Z; Nicklaus MC; Zhou G; Jiang S
Org Lett; 2010 Mar; 12(6):1368-71. PubMed ID: 20184338
[TBL] [Abstract][Full Text] [Related]
38. Convergent synthesis of hydrophilic monomethyl dolastatin 10 based drug linkers for antibody-drug conjugation.
Yang K; Chen B; Gianolio DA; Stefano JE; Busch M; Manning C; Alving K; Gregory RC; Brondyk WH; Miller RJ; Dhal PK
Org Biomol Chem; 2019 Sep; 17(35):8115-8124. PubMed ID: 31460552
[TBL] [Abstract][Full Text] [Related]
39. Structure-activity relationship of kahalalide F synthetic analogues.
Jiménez JC; López-Macià A; Gracia C; Varón S; Carrascal M; Caba JM; Royo M; Francesch AM; Cuevas C; Giralt E; Albericio F
J Med Chem; 2008 Aug; 51(16):4920-31. PubMed ID: 18672864
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological characterization of the histone deacetylase inhibitor largazole and C7- modified analogues.
Souto JA; Vaz E; Lepore I; Pöppler AC; Franci G; Alvarez R; Altucci L; de Lera AR
J Med Chem; 2010 Jun; 53(12):4654-67. PubMed ID: 20491440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
